Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

0.7123 +0.0002 (+0.03%)
Streaming Delayed Price Updated: 1:07 PM EST, Jan 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 6,566
Open 0.7122
Bid (Size) 0.7121 (100)
Ask (Size) 0.7400 (100)
Prev. Close 0.7121
Today's Range 0.7122 - 0.7500
52wk Range 0.6130 - 6.180
Shares Outstanding 461,285,824
Dividend Yield N/A

Performance

YTD
N/A
N/A
1 Month
-30.8%
-30.8%
3 Month
-47.6%
-47.6%
6 Month
-67.7%
-67.7%
1 Year
-79.3%
-79.3%

More News

Read More

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 0.7123
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 01/02/26 01:07 PM ET
What is the market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 328.57M
How many shares of Scinai Immunotherapeutics Ltd. - American Depositary Shares are outstanding?
Scinai Immunotherapeutics Ltd. - American Depositary Shares has 329M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.